On Tuesday, Moderna Inc (NASDAQ: MRNA) was 6.66% up from the session before settling in for the closing price of $24.76. A 52-week range for MRNA has been $23.04 – $48.92.
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -42.94%. When this article was written, the company’s average yearly earnings per share was at 12.18%. With a float of $349.65 million, this company’s outstanding shares have now reached $391.00 million.
Moderna Inc (MRNA) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Moderna Inc stocks. The insider ownership of Moderna Inc is 10.50%, while institutional ownership is 72.90%. The most recent insider transaction that took place on Jun 11 ’25, was worth 8,736. In this transaction Director of this company sold 312 shares at a rate of $28.00, taking the stock ownership to the 580 shares. Before that another transaction happened on Jun 11 ’25, when Company’s Director proposed sale 312 for $28.00, making the entire transaction worth $8,736.
Moderna Inc (MRNA) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -2.91 earnings per share (EPS) during the time that was less than consensus figure (set at -2.76) by -0.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of -2.37 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.18% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.29% during the next five years compared to -42.94% drop over the previous five years of trading.
Moderna Inc (NASDAQ: MRNA) Trading Performance Indicators
You can see what Moderna Inc (MRNA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.73. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.62.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -8.06, a number that is poised to hit -2.63 in the next quarter and is forecasted to reach -6.92 in one year’s time.
Technical Analysis of Moderna Inc (MRNA)
Compared to the last year’s volume of 10.97 million, its volume of 11.83 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 35.66%.
During the past 100 days, Moderna Inc’s (MRNA) raw stochastic average was set at 26.85%, which indicates a significant decrease from 54.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.58 in the past 14 days, which was higher than the 1.34 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $25.86, while its 200-day Moving Average is $28.55. Nevertheless, the first resistance level for the watch stands at $27.12 in the near term. At $27.82, the stock is likely to face the second major resistance level. The third major resistance level sits at $29.03. If the price goes on to break the first support level at $25.21, it is likely to go to the next support level at $24.00. Should the price break the second support level, the third support level stands at $23.30.
Moderna Inc (NASDAQ: MRNA) Key Stats
There are 390,680K outstanding shares of the company, which has a market capitalization of 10.32 billion. As of now, sales total 3,236 M while income totals -3,561 M. Its latest quarter income was 1,016 M while its last quarter net income were -200,000 K.
